Results 21 to 30 of about 1,816 (73)
cIMPACT‐NOW update 10: Recommendations for defining new types for central nervous system tumor classification 
 Brain Pathology, Volume 35, Issue 6, November 2025.Cynthia Hawkins, Kenneth Aldape, David Capper, Andreas von Deimling, Caterina Giannini, Mark R. Gilbert, Thomas S. Jacques, David Jones, Takashi Komori, David N. Louis, Sabine Mueller, MacLean Nasrallah, Brent A. Orr, Arie Perry, Stefan M. Pfister, Felix Sahm, Chitra Sarkar, Matija Snuderl, David Solomon, Pascale Varlet, Pieter Wesseling, Guido Reifenberger   +21 morewiley    +1 more source
Brain Pathology, Volume 35, Issue 6, November 2025.Cynthia Hawkins, Kenneth Aldape, David Capper, Andreas von Deimling, Caterina Giannini, Mark R. Gilbert, Thomas S. Jacques, David Jones, Takashi Komori, David N. Louis, Sabine Mueller, MacLean Nasrallah, Brent A. Orr, Arie Perry, Stefan M. Pfister, Felix Sahm, Chitra Sarkar, Matija Snuderl, David Solomon, Pascale Varlet, Pieter Wesseling, Guido Reifenberger   +21 morewiley    +1 more sourceSterol imbalances and cholesterol‐24‐hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis 
 Brain Pathology, Volume 35, Issue 5, September 2025.We have sought to determine the role that cholesterol metabolism plays in disability worsening and its correlation with progressive MS by analysing patient CSF and post‐mortem tissues using cutting edge mass spectrometry approaches. Key sterol metabolites measured in the CSF link with important disability milestones at the very early stages of MS ...Lauren Griffiths, Kristen Hawkins, Eylan Yutuc, Roberto Angelini, Racheal Fosuah, Manuela Pacciarini, Alison Dickson, Neil Robertson, Laura Childs, Samantha Loveless, Emma Tallantyre, William J. Griffiths, Yuqin Wang, Owain W. Howell   +13 morewiley    +1 more source
Brain Pathology, Volume 35, Issue 5, September 2025.We have sought to determine the role that cholesterol metabolism plays in disability worsening and its correlation with progressive MS by analysing patient CSF and post‐mortem tissues using cutting edge mass spectrometry approaches. Key sterol metabolites measured in the CSF link with important disability milestones at the very early stages of MS ...Lauren Griffiths, Kristen Hawkins, Eylan Yutuc, Roberto Angelini, Racheal Fosuah, Manuela Pacciarini, Alison Dickson, Neil Robertson, Laura Childs, Samantha Loveless, Emma Tallantyre, William J. Griffiths, Yuqin Wang, Owain W. Howell   +13 morewiley    +1 more sourceA companion to the preclinical common data elements for rodent models of pediatric acquired epilepsy: A report of the TASK3‐WG1B, Pediatric and Genetic Models Working Group of the ILAE/AES Joint Translational Task Force 
 Epilepsia Open, Volume 10, Issue S1, Page S53-S86, August 2025.Abstract
Epilepsy syndromes during the early years of life may be attributed to an acquired insult, such as hypoxic–ischemic injury, infection, status epilepticus, or brain trauma. These conditions are frequently modeled in experimental rodents to delineate mechanisms of epileptogenesis and investigate novel therapeutic strategies.Anna‐Maria Katsarou, Hana Kubova, Stéphane Auvin, Massimo Mantegazza, Melissa Barker‐Haliski, Aristea S. Galanopoulou, Christopher A. Reid, Bridgette D. Semple   +7 morewiley    +1 more source
Epilepsia Open, Volume 10, Issue S1, Page S53-S86, August 2025.Abstract
Epilepsy syndromes during the early years of life may be attributed to an acquired insult, such as hypoxic–ischemic injury, infection, status epilepticus, or brain trauma. These conditions are frequently modeled in experimental rodents to delineate mechanisms of epileptogenesis and investigate novel therapeutic strategies.Anna‐Maria Katsarou, Hana Kubova, Stéphane Auvin, Massimo Mantegazza, Melissa Barker‐Haliski, Aristea S. Galanopoulou, Christopher A. Reid, Bridgette D. Semple   +7 morewiley    +1 more sourceProtein Coaggregation in Caribbean Atypical Parkinsonism: The Contribution of Annonacin. [PDF] 
 Neuropathol Appl NeurobiolGonzález-Lizárraga F, Boluda S, Hidalgo JR, Avila CL, Santos CD, Socias B, Medina L, Chaumont H, Akbar D, Roze E, Chehin R, Raisman-Vozari R, Michel PP, Lannuzel A.   +13 moreeuropepmc    +1 more source
Neuropathol Appl NeurobiolGonzález-Lizárraga F, Boluda S, Hidalgo JR, Avila CL, Santos CD, Socias B, Medina L, Chaumont H, Akbar D, Roze E, Chehin R, Raisman-Vozari R, Michel PP, Lannuzel A.   +13 moreeuropepmc    +1 more sourceMitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033. [PDF] 
 Neuro Oncol, 2023 Kros JM, Rushing E, Uwimana AL, Hernández-Laín A, Michotte A, Al-Hussaini M, Bielle F, Mawrin C, Marucci G, Tesileanu CMS, Stupp R, Baumert B, van den Bent M, French PJ, Gorlia T.   +14 moreeuropepmc    +1 more source
Neuro Oncol, 2023 Kros JM, Rushing E, Uwimana AL, Hernández-Laín A, Michotte A, Al-Hussaini M, Bielle F, Mawrin C, Marucci G, Tesileanu CMS, Stupp R, Baumert B, van den Bent M, French PJ, Gorlia T.   +14 moreeuropepmc    +1 more sourceNeuronal pSTAT1 hallmarks synaptic pathology in autoimmune encephalitis against intracellular antigens. [PDF] 
 Acta NeuropatholDi Liberto G, Egervari K, Vogrig A, Spatola M, Piccinno M, Vincenti I, Wagner I, Kreutzfeldt M, Endmayr V, Ostertag K, Rahimi J, Vicino A, Pröbstel AK, Meyronet D, Frank S, Prinz M, Hewer E, Brouland JP, de Leval L, Parkkinen L, Draganski B, Desestret V, Dubey D, Pittock SJ, Roemer SF, Dickson DW, Höftberger R, Irani SR, Honnorat J, Du Pasquier R, Merkler D.   +30 moreeuropepmc    +1 more source
Acta NeuropatholDi Liberto G, Egervari K, Vogrig A, Spatola M, Piccinno M, Vincenti I, Wagner I, Kreutzfeldt M, Endmayr V, Ostertag K, Rahimi J, Vicino A, Pröbstel AK, Meyronet D, Frank S, Prinz M, Hewer E, Brouland JP, de Leval L, Parkkinen L, Draganski B, Desestret V, Dubey D, Pittock SJ, Roemer SF, Dickson DW, Höftberger R, Irani SR, Honnorat J, Du Pasquier R, Merkler D.   +30 moreeuropepmc    +1 more source